|
Speakers & Talk Titles
Choukri Ben Mamoun, PhD / KEYNOTE
Yale University
Human Babesiosis
Brian A. Fallon, MD, MPH (Conference Co-Director, Planning Committee)
Columbia University, New York State Psychiatric Institute
Long COVID and Long Lyme: Mental Health Implications
Co-Presenters
Monica E. Embers, PhD (Conference Co-Director, Planning Committee)
Tulane University
Liz Horn, PhD, MBI
Lyme Disease Biobank
Identifying Pathogens in Post-Mortem Tissue Through the Lyme Disease Biobank Tissue Pipeline
Lawrence Afrin, MD
AIM Center for Personalized Medicine
Mast cell activation disease
John Aucott, MD
Johns Hopkins University
Persistent Symptoms of Lyme Disease
Catherine Brissette, PhD
University of North Dakota
Lyme Neuroborreliosis
Scott P Commins, MD, PhD
University of North Carolina
Alpha-gal syndrome, mast cells and tick bites
Natalie Gukasyan, MD
Columbia University
Psychedelics
Peter J. Gwynne, PhD
University of North Dakota
B. Burgdorferi Metabolism
Alison Hinckley, PhD
Centers for Disease Control and Prevention
Changes to Surveillance for Lyme Disease — United States, 2022
Meghan Catherine Lybecker, PhD
Centers for Disease Control and Prevention
Diagnostics
William V. Padula, OD, SFNAP, FAAO, FNORA
Padula Institute of Vision Rehabilitation
Peri-papillary Ischemia as a Potential Screening Biomarker for Early Detection of Tick-borne Infection
David Putrino, PT, PhD
Icahn School of Medicine at Mount Sinai
Long COVID
Stephen M. Rich, PhD, Professor of Microbiology
University of Massachusetts Amherst
Potential New Lyme Treatment Now Inhibiting Cancer Growth
Peter Rowe, MD
Johns Hopkins University
Managing Orthostatic Intolerance
Klemen Strle, PhD
Tufts University
Immunology, Disease Pathogenesis, PTLDS
Paul Trouillas, MD, PhD, Professor of Neurology
Claude Bernard University
Severe forms of late neuroborreliosis, severe forms of late tick borne neurological disease, Complete remissions obtained in these diseases with long term treatments
| 
